Evidence map›Paper›PMID 39354708›Full record

ReviewImmunology2025

Helios-Illuminating the way for lymphocyte self-control.

Iivo Hetemäki, T Petteri Arstila, Eliisa Kekäläinen

Abstract readReview
In one paragraph

Review in Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Cytotoxic T Cells: Kill, Memorize, and Mask to Maintain Immune Homeostasis.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Iivo HetemäkiTranslational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-6576-3549
T Petteri ArstilaTranslational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Eliisa KekäläinenTranslational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-6045-108X

Funding

Academy of Finland 308912Academy of Finland 308913Päivikki ja Sakari Sohlbergin SäätiöSigrid Juséliuksen SäätiöSuomen Lääketieteen Säätiö
6 · The paper itself

Abstract

Transcription factor Helios, encoded by the IKZF2 gene, has an important role in regulatory T cells by stabilizing their suppressive phenotype. While Helios is prominently expressed in regulatory T cells, its expression extends beyond to include effector T cells, follicular regulatory T cells, B cells, and innate-like lymphocyte populations. Recent characterizations of patients with inborn error of immunity due to damaging IKZF2 variants coupled with translational research on lymphocytes from healthy individuals, have increased our understanding on Helios' multifaceted role in controlling the human adaptive immune system. A less studied role for Helios beyond the stabilizing of regulatory T cells has emerged in directing effector T cell maturation. In the absence of functional Helios, effector T cells acquire more inflammatory phenotype and are prone to senescence. Loss of Helios expression disrupts the regulation of the germinal centre reaction, often resulting in either hypogammaglobulinemia or B cell autoimmunity. This review summarizes findings from studies in both mice and men offering a comprehensive understanding of the impact of the transcription factor Helios on the adaptive immune system.

Indexed as

Ikaros Transcription FactorAdaptive ImmunityAnimalsAutoimmunityB-LymphocytesCell DifferentiationGerminal CenterHumansMiceT-Lymphocytes, RegulatoryIkaros Transcription FactorIKZF2 protein, humanimmunodeficiency diseasesregulatory T cellsT cellT follicular helper celltranscription factors

Identifiers

PMID39354708
PMCPMC11652420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.